Citius Pharmaceuticals Inc at Noble Capital Markets Investor Conference (Virtual) Transcript
Good afternoon, everybody. Thank you for taking the time out to attend our presentation. I'm Leonard Mazur, I'm the Chairman and CEO of Citius Pharmaceutical.
And just bring your attention to -- I'm going to be making forward-looking statements here. What I advise everyone all the time is, please consult the sec.gov for all the up-to-date information. All our filings are located there, or alternatively citiuspharma.com, which is our website.
So, give you a little bit of a background on the company and the history of it. Myself and Myron Holubiak the -- is now the Executive Vice Chair of the company, we actually formed a private company first back in 2013. And that private company was formed to in-license a drug, our first drug that we have, which is Mino-Lok from M.D. Anderson. We did that successfully and funded all of the initial Phase 2b work personally, ourselves at the time.
And then in 2016, we decided that we had to really -- we had a merging with a public company because we began to recognize
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
